Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Huber

Showing results (301-310 of 304) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 304 results.
The Journal of Experimental Medicine|May 15, 2013
CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNFNobuyasu Baba, Vu Quang Van, Keiko Wakahara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid TumorsTinya Abrams, Anu Connor, Christie Fanton, et al.
Molecular Cancer Therapeutics|April 21, 2021
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing MalignanciesQing Sheng, Joseph A D'Alessio, Daniel L Menezes, et al.
Nature Methods|June 3, 2020
Macromolecular modeling and design in Rosetta: recent methods and frameworksJulia Koehler Leman, Brian D Weitzner, Steven M Lewis, et al.
Pageof 31

Showing results (301-310 of 304) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 304 results.
The Journal of Experimental Medicine|May 15, 2013
CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNFNobuyasu Baba, Vu Quang Van, Keiko Wakahara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
Preclinical Antitumor Activity of a Novel Anti-c-KIT Antibody-Drug Conjugate against Mutant and Wild-type c-KIT-Positive Solid TumorsTinya Abrams, Anu Connor, Christie Fanton, et al.
Molecular Cancer Therapeutics|April 21, 2021
PCA062, a P-cadherin Targeting Antibody-Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin-expressing MalignanciesQing Sheng, Joseph A D'Alessio, Daniel L Menezes, et al.
Nature Methods|June 3, 2020
Macromolecular modeling and design in Rosetta: recent methods and frameworksJulia Koehler Leman, Brian D Weitzner, Steven M Lewis, et al.
Pageof 31